Dr Agarwals Healthcare IPO: Key Details, GMP, and Expert Review
28 January 2025 · Sachin Gadekar
Dr Agarwals Healthcare Limited, a leading provider of eye care services in India, is launching its IPO from January 29, 2025, to January 31, 2025. With a total issue size of ₹3,027.26 crores, this IPO presents an exciting opportunity for investors. Let’s explore the details, including GMP (Grey Market Premium), shareholder quota, price band, and an expert review
Overview of Dr Agarwals Healthcare IPO
Particulars
Details
IPO Dates
January 29, 2025 - January 31, 2025
Price Band
₹382 to ₹402 per share
Lot Size
35 shares
Total Issue Size
₹3,027.26 crores
Fresh Issue
₹300 crores
Offer for Sale (OFS)
₹2,727.26 crores
Listing Exchanges
BSE, NSE
Allotment Date
February 3, 2025
Listing Date
February 5, 2025
Grey Market Premium (GMP)
The Dr Agarwals Healthcare IPO GMP today is a critical factor for investors to gauge market sentiment. According to recent data:
The GMP currently stands at ₹42, reflecting strong demand among retail investors.
It’s advisable to keep an eye on the changing GMP trends. Learn more about how GMP impacts IPO investments in our IPO Grey Market Premium Guide.
Shareholder Quota: Who Can Apply?
A unique feature of this IPO is the shareholder quota, which allows existing shareholders of Dr Agarwal's Healthcare Limited to apply under a reserved category.
Shareholders can apply for up to ₹2 lakhs under the quota.
This quota often offers an edge as it’s not open to all retail investors.
If you’re unsure about the differences between IPO and OFS (Offer for Sale), check out our detailed comparison here.
Dr Agarwals Healthcare IPO Review
Competitive Strengths
Largest Eye Care Services Provider: A trusted brand with over 193 facilities across 117 cities in India.
Comprehensive Offerings: End-to-end eye care solutions, including cataract and refractive surgeries, optical products, and pharmaceuticals.
Scalable Model: Hub-and-spoke operational design ensures efficient service delivery.
Proven Financials: Consistent growth, with a revenue increase from ₹450 crores (FY22) to ₹1,025 crores (FY24).
Risks to Consider
High Competition: Growing competition in the healthcare and IPO markets.
Dependency on Key Personnel: The business relies heavily on its doctor-promoters and clinical team.
Expert Verdict
The IPO’s attractive price band and strong GMP indicate promising listing gains. However, long-term investors should consider the high valuation and sectoral risks. For insights into flipping IPOs for quick returns, refer to our article on IPO Flipping.
Key Dates to Remember
Event
Date
IPO Opens
January 29, 2025
IPO Closes
January 31, 2025
Allotment Finalization
February 3, 2025
Refund Initiation
February 4, 2025
Shares in Demat
February 4, 2025
Listing Date
February 5, 2025
Financial Overview
Metric
FY2022
FY2023
FY2024
Revenue
₹450 Cr
₹700 Cr
₹1,025 Cr
Net Profit
₹55 Cr
₹100 Cr
₹145 Cr
EBITDA Margin
18%
22%
25%
How to Apply for Dr Agarwals Healthcare IPO
Use your demat account through apps like Zerodha, Upstox, or Groww.
Check eligibility for the shareholder quota.
Apply for a minimum of 35 shares (₹14,070 investment).
For detailed guidance on how IPOs work, refer to our article on IPO GMP and Grey Market Premium.
FAQS
1. What is the GMP for Dr Agarwals Healthcare IPO today?
The GMP currently stands at ₹42, signaling positive market sentiment. However, it may fluctuate before the listing date.
2. What is the price band for the IPO?
The price band is set at ₹382 to ₹402 per share.
3. Who can apply under the shareholder quota?
Existing shareholders of Dr Agarwal’s Healthcare can apply for up to ₹2 lakhs under this reserved category.
4. When is the IPO listing date?
The IPO is expected to list on February 5, 2025, on the BSE and NSE.
5. Is it a good IPO to invest in?
The IPO offers strong listing potential backed by solid financials and brand value. However, investors should evaluate risks before applying.
Conclusion
Conclusion
Dr Agarwals Healthcare IPO offers a compelling opportunity for retail and institutional investors alike. With its competitive price band, strong GMP, and robust business model, this IPO could yield attractive returns. However, ensure to diversify your investments and consider both risks and rewards before applying.
Stay informed about more investment opportunities through our Knowledge Center. For more on IPO investments.